Each year, The Lymphoma, Leukemia & Myeloma Congress teams up with different organizations, most being focused on raising awareness, gaining funding for research, and providing patient support for different hematologic malignancies. Many of these endorsers will be on-site during the meeting.
Community Oncology Alliance
The Community Oncology Alliance (COA) is a non-profit organization dedicated to advocating for community oncology practices and, most importantly, the patients they serve. COA is the only organization dedicated solely to community oncology where the majority of Americans with cancer are treated. The mission of COA is to ensure that cancer patients receive quality, affordable, and accessible cancer care in their own communities.
Lymphoma Research Foundation
The Lymphoma Research Foundation (LRF) is the nation’s largest lymphoma-focused health organization devoted to improving care through education and support services and improving outcomes through investment in the most promising lymphoma research. LRF’s mission is to eradicate lymphoma and serve all those impacted by this blood cancer. For more information: www.lymphoma.org.
Elsevier Practice Update
PracticeUpdate.com is a free online resource for medical information and expert insight. PracticeUpdate cuts through the mounds of medical literature, helping you focus on key updates in the least amount of time. Our experts review and hand-select the most important information from a variety of sources, adding critical insights and context. We won’t overload your inbox—read it on our site or choose to receive as many or as few newsletters as you would like.
Clinical Lymphoma, Myeloma & Leukemia
Clinical Lymphoma, Myeloma & Leukemia is the official peer-reviewed, monthly journal of the International Myeloma Society and the Society of Hematologic Oncology.
The CLL Society is a patient-driven, physician-curated CLL education, support and research nonprofit 501(c)(3) organization. Dedicated to the unmet needs of CLL (chronic lymphocytic leukemia) and related cancer communities, it focuses on explaining the advances in our understanding of the underlying biology and the rapidly changing therapy options while supporting informed patients and their healthcare providers, researching the CLL journey and supporting basic research. Our goal is to develop real, recent and relevant education for patients, and caregivers and improve CLL care for all. Our motto is SMART PATIENTS GET SMART CARE™.
International Waldenstrom's Macroglobulinemia Foundation
The mission of the IWMF is to offer mutual support and encouragement to the Waldenstrom’s macroglobulinemia (WM) community and others with an interest in the disease, to provide information and educational programs that address patients’ concerns, and to promote and support research leading to better treatments and ultimately, a cure. The IWMF website www.iwmf.com is a valuable resource for publications, quarterly newsletter, network of WM support groups and patient organizations in the US and abroad. IWMF holds a patient educational forum in different areas of the US every year.
Aplastic Anemia and MDS International Foundation
The Aplastic Anemia and MDS International Foundation (AAMDSIF) is the world's leading non-profit health organization dedicated to supporting patients and their families who are living with aplastic anemia, myelodysplastic syndromes (MDS), paroxysmal nocturnal hemoglobinuria (PNH), and related bone marrow failure diseases. Founded in 1983, AAMDSIF provides patient education resources, professional education programs, research grants, and advocacy for bone marrow failure disease research funding.
NewYork-Presbyterian Hospital of Columbia and Cornell
Ranked a top 5 hospital in the nation by U.S. News and World Report, NewYork-Presbyterian Hospital and Weill Cornell Medicine’s oncologists and hematologists provide comprehensive, patient-centered care for people with all forms of cancer and blood disorders. We incorporate the most advanced precision medicine technologies to craft individualized treatment plans for every patient in order to maximize outcomes and quality of life while minimizing potential side effects. With a robust portfolio of over 1,000 clinical trials, the science of tomorrow is treatment that can be accessed at NewYork-Presbyterian Hospital and Weill Cornell Medicine today.
Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society (LLS) is a global leader in the fight to end cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world, provides free information and support services, and is the voice for all blood cancer patients seeking access to quality, affordable, coordinated care. Founded in 1949 and headquartered in Rye Brook, NY, LLS has chapters throughout the United States and Canada. To learn more, visit www.LLS.org.